US 11633405
Steroid hormone pharmaceutical formulations
granted A61KA61K31/565A61K47/14
Quick answer
US patent 11633405 (Steroid hormone pharmaceutical formulations) held by Compass Therapeutics LLC expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/565, A61K47/14, A61K47/44, A61K9/0034